Iovance




Dear Iovance,

We’d like to return JZ. He was accidentally purchased while my toddler was playing games on my phone. He’s is a virus that has quickly infected our operating system.

Sincerely,
Geron
 


Anyone that is still delusional enough to think an acquisition is going to happen I feel really bad for you. This company is now become self sufficient or bust. No one is coming to buy them. Employees may have a year and a half or two at best left to work at Iovance and then it’s collapsing.

The place is the worst kind of toxic. Run while you can.
 


Anyone that is still delusional enough to think an acquisition is going to happen I feel really bad for you. This company is now become self sufficient or bust. No one is coming to buy them. Employees may have a year and a half or two at best left to work at Iovance and then it’s collapsing.

The place is the worst kind of toxic. Run while you can.
The data that they have shown and shared is quite promising plus good morning America shared a story of a money that was fully cured by Amtagvi. I don't know about inner workings but the drug works and data is great.
 


Anyone that is still delusional enough to think an acquisition is going to happen I feel really bad for you. This company is now become self sufficient or bust. No one is coming to buy them. Employees may have a year and a half or two at best left to work at Iovance and then it’s collapsing.

The place is the worst kind of toxic. Run while you can.
Why do you feel so confident with so many patent cliffs coming that there wouldn't be serious interest in TIL therapy ?
 


Why do you feel so confident with so many patent cliffs coming that there wouldn't be serious interest in TIL therapy ?
There is too much competition right around the corner to make this drug too expensive, too risky, and not profitable enough. Not to mention they are no where close to expanding to much bigger and more profitable indications. Without Wall Street or profits, it doesn’t matter how noble the work is, it won’t sustain itself. Investors are done
 


There is too much competition right around the corner to make this drug too expensive, too risky, and not profitable enough. Not to mention they are no where close to expanding to much bigger and more profitable indications. Without Wall Street or profits, it doesn’t matter how noble the work is, it won’t sustain itself. Investors are done
They have great Frontline data with Merck's Keytruda and have better results by far than anyone else out there. They will have fast track for lung cancer coming up. The data there has been amazing as well. People are getting full Remission at 20-30 percent for stage 4 melanoma cancer. That's extremely rare. They have 70 centers opened so far.
 


They have great Frontline data with Merck's Keytruda and have better results by far than anyone else out there. They will have fast track for lung cancer coming up. The data there has been amazing as well. People are getting full Remission at 20-30 percent for stage 4 melanoma cancer. That's extremely rare. They have 70 centers opened so far.
Nice try investor! Ur down huge and ur not any of ur money back! Welcome to investing in shit bag biotech! :)
 






Wow that was one of the worst earnings call I've heard in a while. I would recommend selling stock options once lung cancer data comes out. They must have had some interest in a buyout. Thought they could scale up quickly and up that number and missed by 40 percent plus. I feel for everyone here. This treatment is truly special sadly management isn't. They need a BP or a buyout badly..
 










The company is fine. Stop spamming this board with idiotic Bearish sentiment. Expanding like mad right now. The manufacturing facility will be complete with expansion in less than a year and foreign markets are going to be sending tumor samples in very soon. All good.
 


The company is fine. Stop spamming this board with idiotic Bearish sentiment. Expanding like mad right now. The manufacturing facility will be complete with expansion in less than a year and foreign markets are going to be sending tumor samples in very soon. All good.
I'm generally optimistic but they cut revenue guidance by 40 percent and margins are horrendous. What is being done about that ?
 


The company is fine. Stop spamming this board with idiotic Bearish sentiment. Expanding like mad right now. The manufacturing facility will be complete with expansion in less than a year and foreign markets are going to be sending tumor samples in very soon. All good.

Good job drinking the Koolaid. The company is not fine, unless the BOD makes some serious management changes, no one is going to want to invest in Iovance. They are unable to sustain themselves as is, so another stock dilution is coming, this company is no longer an appeal to anyone. If it were people would be BUYING UP stock right now at the low low price it is. How many stocks have you seen come back from $1 and change? Class action lawsuit to boot, just nail in the coffin.
 


The company is fine. Stop spamming this board with idiotic Bearish sentiment. Expanding like mad right now. The manufacturing facility will be complete with expansion in less than a year and foreign markets are going to be sending tumor samples in very soon. All good.
I mean they lied to everyone about revenue guidance they knew they had no shot at $450 million revenue in March and kept reaffirming guidance. Then the margins were beyond atrocious and they clearly didn't think through how difficult this entire operation would be. And with the exception of 25,000 shares being bought by an insider nobody else has made any buys yet. The treatment is great and works but they massively underestimated how difficult the whole logistics process would be.
 


It's never a good sign when the CFO jumps ship. He probably advised Fred to massively cut operating expenses given the ~200 million guidance reduction. Fred refused to make the deep cuts necessary to keep company afloat. The stock is headed toward zero and company will run out of cash by early next year and will become a going concern in Q3. Nobody wants to touch this. TIL is just hard to sell.
 



Write your reply...